Santiago de Compostela, Spain

Eva Alonso Lopez

This inventor holds 1 USPTO granted patent. Top assignees: Texas A&M University System, Universidade De Santiago De Compostela. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eva Alonso Lopez. Retrieved from https://idiyas.com/inventor/eva-alonso-lopez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eva Alonso Lopez: Innovator in Immunosuppressive and Neuroprotective Agents

Introduction

Eva Alonso Lopez is a distinguished inventor based in Santiago de Compostela, Spain. She has made significant contributions to the field of immunology and neuroprotection through her innovative research and patenting efforts. Her work focuses on the development of Gracilin A and its congeners, which have potential applications as immunosuppressive and neuroprotective agents.

Latest Patents

Eva Alonso Lopez holds a patent for "Gracilin A and congeners as immunosuppressive and neuroprotective agents." This patent outlines the methods for utilizing Gracilin A congeners in various therapeutic applications, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Eva has worked with notable institutions, including the Texas A&M University System and the Universidade De Santiago De Compostela. Her experience in these esteemed organizations has allowed her to collaborate with leading researchers and contribute to groundbreaking studies in her field.

Collaborations

Eva has collaborated with esteemed colleagues such as Daniel Romo and Mikail E Abbasov. These partnerships have enriched her research and expanded the impact of her work in the scientific community.

Conclusion

Eva Alonso Lopez is a remarkable inventor whose work in immunosuppressive and neuroprotective agents has the potential to make a significant impact in medicine. Her dedication to research and innovation continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…